首页> 美国卫生研究院文献>Case Reports in Womens Health >Use of dexamethasone remdesivir convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report
【2h】

Use of dexamethasone remdesivir convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report

机译:使用地塞米松Remdesivir临时等离子体和易于定位在治疗怀孕中严重的Covid-19感染:案例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at 26 weeks of gestation with acute respiratory distress syndrome secondary to COVID-19 infection treated with dexamethasone, remdesivir, convalescent plasma and mechanical ventilation. Cesarean delivery was performed at 29 weeks due to worsening maternal status. This case offers insight into the assessment and successful use of treatment strategies, including dexamethasone, remdesivir, convalescent plasma, early prone positioning, conservative fluid management, permissive hypoxia and low tidal volume parameters with ventilator support for pregnancies affected by severe COVID-19 infection.
机译:怀孕的Covid-19病毒严重感染为产科医生和关键护理专家提供独特的管理挑战。我们在妊娠26周内举行妊娠26周的案件,急性呼吸窘迫综合征中继发于Covid-19感染,雷米松,恢复症,康复等离子体和机械通风。由于孕产妇状况恶化,剖宫产递送在29周进行。本案件提供了对评估和成功使用治疗策略的洞察力,包括地塞米松,Remdesivir,康复等离子体,早期俯卧定位,保守流体管理,呼吸缺氧和低潮汐卷参数,呼吸机支持受严重的Covid-19感染影响的妊娠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号